Medicament formulation with a controlled release of an...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4709 (2006.01) A61K 9/00 (2006.01)

Patent

CA 2304135

The invention relates to drug formulations which comprise 1-cyclopropyl-7- ([S,S]- 2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3- quinolonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.

L'invention concerne des formulations médicamenteuses contenant comme principe actif de l'acide 1-cyclopropyl -7-([S,S]-2,8-diazabicyclo [4.3.0]non-8-yl)-6- fluor-1,4-dihydro-8- méthoxy-4-oxo -3-quinolonecarboxylique et/ou leurs sels et/ou hydrates pharmaceutiquement tolérables, qui libèrent le principe actif contenu avec une vitesse définie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicament formulation with a controlled release of an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament formulation with a controlled release of an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament formulation with a controlled release of an... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647296

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.